C: alternative experimental designs

6 important questions on C: alternative experimental designs

What are pilot or feasibility trials

Is performed in advance of a future definitive randomised control trial enhance the probability of success of this future RCT
  • Aim is to assess the feasibility of methods and procedures intended to be used in a larger scale study
    • Feasibility
    • Randomisation
    • Assessment
    • Acceptability and feasibility
  • NOT used for hypothesis testing
  • Could be used for sample size calculation

What is a cluster randomised trial

  • Randomisation at level of cluster (e.g. Practice, hospital) and not at level of individual patient
  • Outcome measurement at level of individual patient
  • Advantages in case of:
    • Intervention aimed at cluster level (e.g. Department)
    • Difficult for HCP's to switch between treatment
    • Conamination
  • Risk of bias less straightforward
    • RoB at cluster level (baseline imbalance, selective drop out)
    • RoB at individual level (differential individual recruitment or differential consent procedures

What are some issues to take into consideration regarding cluster randomised trial

  • Unit of randomisation may be (too?) small for true randomisation
  • Patients are 'clustered' (e.g. In GP practice) the sample size calculation needs to take that into account
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

Non-inferiority trial (NI)

  • A NI trial seeks to determine whether a new treatment is not worse than a reference treatment by more than an acceptable amount
  • Because proof of exact equivalence is impossible, a restated margin of NI (triangle) for the treatment effect in a primary patient outcome is defined
  • Equivalence trials are very similar, except that equivalence is defined as the treatment effect being -(triangle) and +(triangle)

What are some issues w/ non-inferiority trial (NI)

  • Is the gain (e.g. Less burden ) of the new treatment a real gain?
  • Choice appropriate comparator (at least not placebo)...
  • Current treatment is better then placebo
  • Determining NI margin (triangle) is a challenge
  • ITT vs per protocol analyses
  • In sum: interpretation is not straightforward

Phase I to IV trials: how interventions develop into mature interventions

  1. Phase 1: After promising findings w/ animal experiments -> healthy volunteers
  2. Phase 2: For first time relevant patients are targeted -> assess safety and optimal dose -> focus on intermediate outcomes
  3. Phase 3: Focus on real life situations with real patients
  4. Phase 4: postmarketing (surveillance) mainly to detect rare side effects

The question on the page originate from the summary of the following study material:

  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
Remember faster, study better. Scientifically proven.
Trustpilot Logo